Geode Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.5M | Buy |
|
|||||
|
2025
Q1 | $1.81M | Buy |
|
|||||
|
2024
Q4 | $1.96M | Sell |
|
|||||
|
2024
Q3 | $974K | Buy |
|
|||||
|
2024
Q2 | $852K | Sell |
|
|||||
|
2024
Q1 | $1.94M | Buy |
|
|||||
|
2023
Q4 | $1.46M | Buy |
|
|||||
|
2023
Q3 | $9.16M | Buy |
|
|||||
|
2023
Q2 | $12.8M | Buy |
|
|||||
|
2023
Q1 | $9.02M | Buy |
|
|||||
|
2022
Q4 | $16.7M | Buy |
|
|||||
|
2022
Q3 | $16.2M | Buy |
|
|||||
|
2022
Q2 | $13.4M | Buy |
|
|||||
|
2022
Q1 | $14.6M | Buy |
|
|||||
|
2021
Q4 | $11.8M | Buy |
|
|||||
|
2021
Q3 | $14.3M | Buy |
|
|||||
|
2021
Q2 | $12.6M | Buy |
|
|||||
|
2021
Q1 | $9.5M | Buy |
|
|||||
|
2020
Q4 | $2.1M | Sell |
|
|||||
|
2020
Q3 | $1.03M | Sell |
|
|||||
|
2020
Q2 | $668K | Sell |
|
|||||
|
2020
Q1 | $610K | Buy |
|
|||||
|
2019
Q4 | $1.1M | Buy |
|
|||||
|
2019
Q3 | $530K | Buy |
|
|||||
|
2019
Q2 | $1.06M | Buy |
|
|||||
|
2019
Q1 | $2.8M | Buy |
|
|||||
|
2018
Q4 | $2.81M | Buy |
|
|||||
|
2018
Q3 | $3.99M | Buy |
|
|||||
|
2018
Q2 | $5.33M | Buy |
|
|||||
|
2018
Q1 | $4.29M | Buy |
|
|||||
|
2017
Q4 | $5.57M | Buy |
|
|||||
|
2017
Q3 | $5.47M | Buy |
|
|||||
|
2017
Q2 | $3.9M | Buy |
|
|||||
|
2017
Q1 | $3.52M | Buy |
|
|||||
|
2016
Q4 | $2.82M | Buy |
|
|||||
|
2016
Q3 | $1.31M | Buy |
|
|||||
|
2016
Q2 | $905K | Buy |
|
|||||
|
2016
Q1 | $819 | Buy |
|
|||||
|
2015
Q4 | $985K | Buy |
|